Evidence map›Paper›PMID 39473742›Full record

ArticleTurkish journal of medical sciences2024

Distribution and classifications of

Yüksel Gezgin, Berkay Kirnaz, Rauf Baylarov, Afig Berdeli

Abstract read
In one paragraph

Article in Turkish journal of medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yüksel GezginDivision of Molecular Medicine, Department of Pediatrics, Faculty of Medicine, Ege University, İzmir, Turkiye.ORCID https://orcid.org/0000-0001-5812-1882
Berkay KirnazDivision of Molecular Medicine, Department of Pediatrics, Faculty of Medicine, Ege University, İzmir, Turkiye.ORCID https://orcid.org/0000-0003-2913-5788
Rauf BaylarovDivision of Pediatric Nephrology, Department of Pediatrics, Azerbaijan State Medical University, Baku, Azerbaijan.ORCID https://orcid.org/0000-0002-5382-7429
Afig BerdeliDivision of Molecular Medicine, Department of Pediatrics, Faculty of Medicine, Ege University, İzmir, Turkiye.ORCID https://orcid.org/0000-0002-4791-8367

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/aim: Autosomal recessive polycystic kidney disease is an inherited kidney disease. This study aims to detect rare and common DNA variants of the Materials and methods: NGS analysis was performed on the DNA of 304 patients who were referred to Ege University Molecular Medicine Laboratory with suspected polycystic kidney disease. Results: As a result, a total of 82 different DNA variants, 16 of which were novel, were detected. The breakdown of the variants found is as follows: 73 (89.02%) were missense variants, six (7.32%) nonsense variants, two (2.44%) frameshift deletions, and one (1.22%) nonframeshift deletion. According to The American College of Medical Genetics and Genomics classification of these variants, 26 were benign (Class 5), two were likely benign (Class 4), 36 were of uncertain significance (Class 3), and nine were likely pathogenic (Class 2), nine of which are pathogenic variants (Class 1). Heterozygosity was found in 39 (63.9%) patients, homozygosity in six (9.8%) patients, compound heterozygosity in 12 (19.7%) patients, and complex genotype in four (6.6%) patients in which variants in Class 1, Class 2 and Class 3 were determined according to ACMG classification. When the exon distributions of the DNA variants detected in the Conclusion: This fast and economical molecular diagnostic approach will provide a reliable prenatal diagnostic option, enabling definitive disease diagnosis and the identification of carriers.

Indexed as

High-Throughput Nucleotide SequencingReceptors, Cell SurfaceAdolescentAdultChildChild, PreschoolFemaleGenetic VariationHumansMalePolycystic Kidney, Autosomal RecessiveTurkeyYoung AdultPKHD1 protein, humanReceptors, Cell SurfaceAutosomal recessive polycystic kidney diseasemissense variantnext generation sequencingPKHD1 geneprenatal diagnosis

Identifiers

PMID39473742
PMCPMC11518325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.